Found: 30
Select item for more details and to access through your institution.
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participants.
- Published in:
- Frontiers in Aging Neuroscience, 2024, p. 1, doi. 10.3389/fnagi.2024.1447944
- By:
- Publication type:
- Article
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01276-6
- By:
- Publication type:
- Article
Serum and Cerebrospinal Fluid Uric Acid Levels in Lewy Body Disorders: Associations with Disease Occurrence and Amyloid-β Pathway.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 27, n. 1, p. 119, doi. 10.3233/JAD-2011-110587
- By:
- Publication type:
- Article
Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
- Published in:
- 2011
- By:
- Publication type:
- journal article
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.834580
- By:
- Publication type:
- Article
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.
- Published in:
- Frontiers in Aging Neuroscience, 2016, p. 1, doi. 10.3389/fnagi.2016.00147
- By:
- Publication type:
- Article
Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.
- Published in:
- Frontiers in Aging Neuroscience, 2016, p. 1, doi. 10.3389/fnagi.2016.00121
- By:
- Publication type:
- Article
Mild Parkinsonian Signs in the Elderly – Is There an Association with PD? Crossectional Findings in 992 Individuals.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092878
- By:
- Publication type:
- Article
Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.
- Published in:
- EMBO Journal, 2008, v. 27, n. 2, p. 350, doi. 10.1038/sj.emboj.7601952
- By:
- Publication type:
- Article
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00706-1
- By:
- Publication type:
- Article
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00627-5
- By:
- Publication type:
- Article
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00476-2
- By:
- Publication type:
- Article
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0209-7
- By:
- Publication type:
- Article
Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 2, p. 451, doi. 10.1007/s00415-014-7584-4
- By:
- Publication type:
- Article
Risk factors and prodromal markers and the development of Parkinson's disease.
- Published in:
- Journal of Neurology, 2014, v. 261, n. 1, p. 180, doi. 10.1007/s00415-013-7171-0
- By:
- Publication type:
- Article
Association of elevated cerebrospinal fluid levels of the longevity protein α‐Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 10, p. 1, doi. 10.1111/ene.16388
- By:
- Publication type:
- Article
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1557, doi. 10.1111/ene.14733
- By:
- Publication type:
- Article
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149349
- By:
- Publication type:
- Article
Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease.
- Published in:
- Movement Disorders, 2023, v. 38, n. 5, p. 907, doi. 10.1002/mds.29399
- By:
- Publication type:
- Article
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.
- Published in:
- Movement Disorders, 2021, v. 36, n. 11, p. 2595, doi. 10.1002/mds.28704
- By:
- Publication type:
- Article
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PD<sub>GBA</sub>.
- Published in:
- Movement Disorders, 2021, v. 36, n. 5, p. 1216, doi. 10.1002/mds.28472
- By:
- Publication type:
- Article
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD.
- Published in:
- Neuroepidemiology, 2015, v. 45, n. 4, p. 282, doi. 10.1159/000439221
- By:
- Publication type:
- Article
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cognitive impairment in Glucocerebrosidase (GBA)‐associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.
- Published in:
- Movement Disorders, 2017, v. 32, n. 12, p. 1780, doi. 10.1002/mds.27199
- By:
- Publication type:
- Article
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 2, p. 216, doi. 10.1002/mds.25192
- By:
- Publication type:
- Article
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00820-0
- By:
- Publication type:
- Article